Open the mobile version, with barcode scanning
Class III Terminated

Contrave (naltrexone HCl and bupropion HCl) Extended-Release Tablets, 8 mg/90 mg, 120-count bottle, Rx only, Distributed by Orexigen therapeutics, Inc., La Jolla, CA 92037, NDC 51267-890-99.

Why: Defective Container: Customer complaints of punctures in the bottle.

Company
Orexigen Therapeutics, Inc.
La Jolla, CA, United States
Reported
Aug 22, 2018
Recall started
Aug 9, 2018
Ended
Nov 15, 2019
Where sold
Nationwide in the USA
Amount
95,296 bottles
Full product description
Contrave (naltrexone HCl and bupropion HCl) Extended-Release Tablets, 8 mg/90 mg, 120-count bottle, Rx only, Distributed by Orexigen therapeutics, Inc., La Jolla, CA 92037, NDC 51267-890-99.
Lots / codes affected
Lot #: ZCXM, Exp 01NOV2020; ZCXN, Exp 02NOV2020; ZCXP, Exp 09NOV2020; ZCXS, 10NOV2020; ZCXT, Exp 13NOV2020; and ZCXV, Exp 17NOV2020

Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.